TRIN

TRIN

USD

Trinity Capital Inc. Common Stock

$15.175+0.075 (0.497%)

Prix en Temps Réel

Services financiers
Asset Management
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$15.100

Haut

$15.180

Bas

$14.970

Volume

2.25M

Fondamentaux de l'Entreprise

Capitalisation Boursière

1.1B

Industrie

Asset Management

Pays

United States

Statistiques de Trading

Volume Moyen

0.78M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $12.5Actuel $15.175Haut $16.82

Actualités Connexes

PR Newswire

Trinity Capital Inc. Provides Equipment Financing to Bobbie, Bolstering Domestic Infant Formula Industry

Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the funding of equipment and other asset...

Voir plus
Trinity Capital Inc. Provides Equipment Financing to Bobbie, Bolstering Domestic Infant Formula Industry
GlobeNewswire

Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.

$50 million drawn down at closing, with access to up to an additional $80 millionStrengthens Company's financial position; enables initiation of phase 3 clinical trial of CAN-2409 in non-small cell lung cancer

Voir plus
Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
PR Newswire

Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer

Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment of $130 million in growth...

Voir plus
Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
PR Newswire

Trinity Capital Inc. Expands Life Sciences Vertical with Appointment of Paul D'Agrosa

Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the appointment of Paul D'Agrosa as...

Voir plus
Trinity Capital Inc. Expands Life Sciences Vertical with Appointment of Paul D'Agrosa

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.